Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nck-associated protein 1-like (NCKAP1L) is a hematopoietic-specific, highly conserved cytoplasmic protein that is a critical component of the WAVE regulatory complex, responsible for actin cytoskeleton organization. It is selectively expressed in hematopoietic cells, where it regulates lymphocyte development, activation, proliferation, immune synapse formation, neutrophil and macrophage migration, and phagocytic cup formation. NCKAP1L operates downstream of Rac1 and Cdk5 to stimulate F-actin polymerization in response to immune receptor and cytokine signaling. Importantly, biallelic mutations in NCKAP1L cause immunodeficiency with autoinflammation and lymphoproliferation; this clinical syndrome is marked by defective immune activation, early T cell exhaustion, impaired migration and phagocytosis, and features of actinopathies. In animal research, a minor isoform of NCKAP1L also regulates intrahepatic biliary network formation, indicating specialized roles beyond the immune system.
Not established for direct pharmacological targeting. Rac1 inhibitors and Cdk5 pathway modulators may negatively influence NCKAP1L-dependent processes by interfering with actin polymerization. Any drug affecting actin cytoskeletal regulation could theoretically influence NCKAP1L-related pathways.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nck-associated protein 1-like (NCKAP1L).